Human platelets activate porcine endothelial cells through a CD154-dependent pathway

Area of Science:

• Immunology
• Transplantation Biology
• Cellular Interactions

Background:

• Delayed xenograft rejection involves endothelial cell activation and thrombosis.
• Human platelets may directly activate porcine endothelium (PEC).
• Investigating the role of platelet CD154 and PEC CD40 interaction.

Purpose of the Study:

• To determine if human platelets activate PEC.
• To elucidate the mechanism of PEC activation by human platelets.
• To assess the potential of targeting CD154-CD40 interaction for xenotransplantation.

Main Methods:

• Platelet activation induced by thrombin, confirmed by CD62P and CD154 expression.
• Co-incubation of activated human platelets or D1.1 cells with PEC.
• Assessment of PEC activation via CD62E expression.
• Inhibition studies using anti-CD154 monoclonal antibody (hu5c8).

Main Results:

• Resting platelets without CD154 did not activate PEC.
• Activated human platelets expressing CD154 induced PEC activation.
• This activation was completely inhibited by anti-CD154 antibody.
• Human D1.1 cells expressing CD154 also activated PEC in a CD154-dependent manner.

Conclusions:

• Human CD154 on activated platelets interacts with PEC CD40, causing PEC activation.
• This CD154-CD40 interaction is implicated in delayed xenograft rejection.
• Targeting CD154 with monoclonal antibodies offers a therapeutic strategy for xenotransplantation.